Gladstone is 100% dedicated to disease-focused research, with more than 600 biologists, chemists, engineers, and data scientists who bring a deeply mechanistic understanding of how the human body works and what goes wrong in disease.

But we don’t attempt to address every disease. We’ve chosen to focus on cardiology, neurology, immunology, and virology—and we’ve built teams of the world’s top researchers and physician-scientists to work collaboratively in these areas to tackle the biggest problems, with an eye for clinical success.

Learn more about the Gladstone Difference.

Gladstone NOW: The Campaign
 Join Us On The Journey

Up Next


Science in Seconds | Researchers Pinpoint Key Gene Behind Heart Defects in Down Syndrome

Science in Seconds with Deepak Srivastava
Video November 3, 2025

Science in Seconds | Researchers Pinpoint Key Gene Behind Heart Defects in Down Syndrome

In this video, Gladstone scientists share how they used stem cells, gene editing, and AI to identify a gene driving heart defects in Down syndrome—and how reducing its levels in mice restored normal heart development, offering hope for future treatments

Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Pollard Lab Srivastava Lab AI Big Data CRISPR/Gene Editing Human Genetics Stem Cells/iPSCs

Science in Seconds | The Thinking Microscope: Research Powered by an AI Brain

Science in Seconds featuring Steve Finkbeiner
Video October 15, 2025

Science in Seconds | The Thinking Microscope: Research Powered by an AI Brain

In this video, Steve Finkbeiner and Jeremy Linsley showcase Gladstone’s groundbreaking “thinking microscope”—an AI-powered system that can design, conduct, and analyze experiments autonomously to uncover new insights into diseases like Alzheimer’s, Parkinson’s, and ALS.

Gladstone Experts ALS Alzheimer’s Disease Parkinson’s Disease Neurological Disease Finkbeiner Lab AI Big Data

More News